INV-1120
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INV-1120, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors [Phase 1]